Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;39:536-542
doi: 10.1161/hy0202.103048
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ward, S. C.
Right arrow Articles by Hamlyn, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ward, S. C.
Right arrow Articles by Hamlyn, J. M.
Related Collections
Right arrow Other hypertension
Right arrow Heart failure - basic studies
Right arrow Hypertension - basic studies
Right arrow Ion channels/membrane transport
Right arrow Peripheral vascular disease
Right arrow Type 2 diabetes
Right arrow Platelets

(Hypertension. 2002;39:536.)
© 2002 American Heart Association, Inc.


Scientific Contributions

Novel Receptors for Ouabain: Studies in Adrenocortical Cells and Membranes

Stephen C. Ward; Bruce P. Hamilton; John M. Hamlyn

From the Departments of Physiology and Medicine, School of Medicine, University of Maryland, and The Veterans Administration Medical Center, Baltimore, Md.

Correspondence to John M. Hamlyn, PhD, Department of Physiology, School of Medicine, University of Maryland, 655 West Baltimore St, Baltimore, MD 21201. E-mail jhamlyn{at}umaryland.edu

Sodium-potassium pumps (Na pumps) are the only known plasma membrane receptors for cardiac glycosides. However, adrenocortical cells secrete an endogenous ouabain via an unknown mechanism that is subject to feedback inhibition via the cell surface. In addition, recent studies suggest that the induction of sustained hypertension by ouabain analogs in rats may be independent of Na pump inhibition. Accordingly, we used bovine adrenocortical cells and membranes to search for novel binding sites for ouabain. In high extracellular potassium solutions, the binding of ouabain to the Na pumps of cultured cells was suppressed, yet residual specific binding of 3H-ouabain was observed. In high extracellular potassium, Scatchard analyses revealed a novel class of ouabain binding sites with high affinity (<50 nmol/L, <2.5x105 sites/cell) that was distinct from the low-affinity Na pump sites (>1 µmol/L, 4.5x106 sites/cell). Analysis of the kinetics for the dissociation of 3H-ouabain from intact cells revealed components whose t0.5 values were 6.5 minutes, 3.3 hours, and 33 hours and associated with novel sites, Na pumps, and lysosomal recycling, respectively. Studies with isolated membranes under ligand conditions where the participation of Na pumps was minimized revealed specific ouabain binding to novel sites that was saturable, time-dependent, of high affinity (Kd{approx}15 nmol/L), and of low density (apparent Bmax=0.23 pmol/mg, c.f., Na pumps=10.2 pmol/mg). Ouabain binding to the novel sites was stimulated by high concentrations of KCl but was not affected by aldosterone or cortisol up to 30 µmol/L. Novel sites were not detected in skeletal muscle or liver membranes. Photoaffinity studies followed by SDS-PAGE showed ouabain-protectable labeling of membrane polypeptides with apparent molecular weights of 143, 113, and 65 kDa. We conclude that adrenocortical cells express ouabain receptors that are distinct from Na pumps. These novel receptors may be involved in the regulation and/or secretion of endogenous ouabain.


Key Words: digitalis • ouabain • adrenal gland • sodium pump • glycosides




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Oweis, L. Wu, P. R. Kiela, H. Zhao, D. Malhotra, F. K. Ghishan, Z. Xie, J. I. Shapiro, and J. Liu
Cardiac glycoside downregulates NHE3 activity and expression in LLC-PK1 cells
Am J Physiol Renal Physiol, May 1, 2006; 290(5): F997 - F1008.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. A. Akimova, A. Y. Bagrov, O. D. Lopina, A. V. Kamernitsky, J. Tremblay, P. Hamet, and S. N. Orlov
Cardiotonic Steroids Differentially Affect Intracellular Na+ and [Na+]i/[K+]i-independent Signaling in C7-MDCK Cells
J. Biol. Chem., January 7, 2005; 280(1): 832 - 839.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Cereijido, R. G. Contreras, and L. Shoshani
Cell Adhesion, Polarity, and Epithelia in the Dawn of Metazoans
Physiol Rev, October 1, 2004; 84(4): 1229 - 1262.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. V. Rossoni, M. Salaices, M. Miguel, A. M. Briones, L. A. Barker, D. V. Vassallo, and M. J. Alonso
Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors
Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H2110 - H2118.
[Abstract] [Full Text] [PDF]